100 related articles for article (PubMed ID: 24947335)
1. Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats.
Ogawa J; Yokota A; Araki T; Aomori T; Nakamura T; Yamamoto K; Koshiishi I
Biopharm Drug Dispos; 2014 Sep; 35(6):362-71. PubMed ID: 24947335
[TBL] [Abstract][Full Text] [Related]
2. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1.
van Montfoort JE; Stieger B; Meijer DK; Weinmann HJ; Meier PJ; Fattinger KE
J Pharmacol Exp Ther; 1999 Jul; 290(1):153-7. PubMed ID: 10381771
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion.
Ringe KI; Hinrichs J; Merkle EM; Weismüller TJ; Wacker F; Meyer BC
J Magn Reson Imaging; 2014 Jul; 40(1):106-12. PubMed ID: 24923477
[TBL] [Abstract][Full Text] [Related]
5. Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver.
Lagadec M; Doblas S; Giraudeau C; Ronot M; Lambert SA; Fasseu M; Paradis V; Moreau R; Pastor CM; Vilgrain V; Daire JL; Van Beers BE
Radiology; 2015 Feb; 274(2):379-86. PubMed ID: 25289480
[TBL] [Abstract][Full Text] [Related]
6. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
[TBL] [Abstract][Full Text] [Related]
7. Value of gadoxetate biliary transit time in determining hepatocyte function.
Wu J; Li H; Lin Y; Chen Z; Zhong Q; Gao H; Fu L; Sandrasegaran K
Abdom Imaging; 2015 Jan; 40(1):95-101. PubMed ID: 25056714
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
9. Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition.
Ulloa JL; Stahl S; Yates J; Woodhouse N; Kenna JG; Jones HB; Waterton JC; Hockings PD
NMR Biomed; 2013 Oct; 26(10):1258-70. PubMed ID: 23564602
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of gadoxetate disodium-enhanced MR cholangiography in chronic cholestatic biliary disease.
Kühn JP; Spoerl M; Nassif A; Mester M; Weitschies W; Siegmund W; Hosten N; Mensel B
Clin Radiol; 2014 Oct; 69(10):1027-33. PubMed ID: 24957855
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging: Monitoring Transporter-Mediated Processes in Healthy Volunteers.
Georgiou L; Penny J; Nicholls G; Woodhouse N; Blé FX; Hubbard Cristinacce PL; Naish JH
Invest Radiol; 2017 Feb; 52(2):111-119. PubMed ID: 28002117
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal?
Ringe KI; Husarik DB; Gupta RT; Boll DT; Merkle EM
Eur J Radiol; 2011 Aug; 79(2):201-5. PubMed ID: 20347540
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
15. Modeling Gadoxetate Liver Uptake and Efflux Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging Enables Preclinical Quantification of Transporter Drug-Drug Interactions.
Georgiou L; Penny J; Nicholls G; Woodhouse N; Blé FX; Naish JH; Hubbard Cristinacce PL
Invest Radiol; 2018 Sep; 53(9):563-570. PubMed ID: 29771727
[TBL] [Abstract][Full Text] [Related]
16. A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function.
Karageorgis A; Lenhard SC; Yerby B; Forsgren MF; Liachenko S; Johansson E; Pilling MA; Peterson RA; Yang X; Williams DP; Ungersma SE; Morgan RE; Brouwer KLR; Jucker BM; Hockings PD
PLoS One; 2018; 13(5):e0197213. PubMed ID: 29771932
[TBL] [Abstract][Full Text] [Related]
17. Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.
Choi Y; Huh J; Woo DC; Kim KW
Br J Radiol; 2016; 89(1058):20150666. PubMed ID: 26693795
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance Imaging.
Lenhard SC; Lev M; Webster LO; Peterson RA; Goulbourne CN; Miller RT; Jucker BM
Toxicol Pathol; 2016 Jan; 44(1):51-60. PubMed ID: 26516164
[TBL] [Abstract][Full Text] [Related]
19. A LC-MS/MS method to evaluate the hepatic uptake of the liver-specific magnetic resonance imaging contrast agent gadoxetate (Gd-EOB-DTPA) in vitro and in humans.
Jia J; Keiser M; Nassif A; Siegmund W; Oswald S
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 891-892():20-6. PubMed ID: 22391331
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.
Giraudeau C; Leporq B; Doblas S; Lagadec M; Pastor CM; Daire JL; Van Beers BE
Eur Radiol; 2017 May; 27(5):1804-1811. PubMed ID: 27553933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
